BLASTOCYSTIS HOMINIS--STRUCTURE, PHYSIOLOGY AND PATHOGENICITY

在过去的16年里，人们将芽囊原虫重新分类为 原生动物，把它从酵母中移走，在那里它已经枯萎了70年。 年 B。人现在被确定为孢子虫的一员， 人类和灵长类动物的肠道寄生虫和病原体。 当B.人在粪便中大量存在， 腹泻通常会发生。 首选药物是甲硝唑。 严重感染的患者已在临床中心接受治疗。 有1例死亡病例。 这种原生动物现在是国家和国际利益的主题， 寄生虫学家和医生作为一个过程中腹泻的人。治疗 通常是甲硝唑 还使用甲氧苄啶-磺胺甲恶唑 成功地 对B的研究进展缓慢。人的线粒体，但我们在 最后有足够的数据发表。 我们每周都会接到来自美国各地的电话， 提出诊断和治疗囊胚的问题。

Work over the past sixteen years has reclassified Blastocystis hominis as a protozoan, removing it from the yeasts where it has languished for seventy years. B. hominis is now firmly established as a member of the Sporozoa, an intestinal parasite and pathogen of man and primates. When B. hominis is present in large numbers in stool contents, marked diarrhea is usually experienced. The drug of choice is metronidazole. Patients with severe infection have been treated at the Clinical Center. There was one fatal case. This protozoan is now a subject of national and international interest to parasitologists and physicians as a course of diarrhea in man. Treatment is usually with metronidazole. Trimethoprim-sulfamethoxazole is also used successfully. Progress has been slow on research into B. hominis mitochrondria, but we at last have sufficient data for publication. We receive calls from around the United States a number of times each week, to present problems in diagnosis and treatment of blastocystis.